Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries

OBJECTIVES: The use of the NNRTI rilpivirine in low- and middle-income countries (LMICs) is under debate. The main objective of this study was to provide further clinical insights and biochemical evidence on the usefulness of rilpivirine in LMICs. PATIENTS AND METHODS: Rilpivirine resistance was ass...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Antimicrob Chemother
Auteurs principaux: Neogi, Ujjwal, Häggblom, Amanda, Singh, Kamalendra, Rogers, Leonard C., Rao, Shwetha D., Amogne, Wondwossen, Schülter, Eugen, Zazzi, Maurizio, Arnold, Eddy, Sarafianos, Stefan G., Sönnerborg, Anders
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4710214/
https://ncbi.nlm.nih.gov/pubmed/26518047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkv359
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires